Arkolith/Insider Trading/JAZZ/Form 4

Carr Patricia

SVP, Chief Accounting OfficerJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Mar 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$456K
Net Open-Market Flow
-$456K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 27, 2026Sell(S)1K$190.91$213K9K
Feb 26, 2026Sell(S)1K$194.11$243K10K
Feb 26, 2026Grant(A)2K—$012K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001784606-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML